Sangamo Therapeutics

+$0.06 (+0.63%) Today
-$0.02 (-0.21%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.

About SGMO

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases.

CEO
Alexander D. Macrae
Employees
413
Headquarters
Brisbane, California
Founded
1995

SGMO Key Statistics

Market Cap
1.40B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
956.40K
High Today
$9.65
Low Today
$9.47
Open Price
$9.62
Volume
714.25K
52 Week High
$19.43
52 Week Low
$8.90

SGMO Earnings

-$0.37
-$0.23
-$0.10
$0.04
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure